semaglutide for obesity walnut creek 🚨 Oral 25 mg delivers double-digit weight loss in OASIS-4 (Phase 3 trial) - Long-term weight loss effects of

GLP-1 medications for weight loss are typically prescribed to adults who have a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with weight-related health conditions, such as type 2 diabetes, high blood pressure, or sleep apnea

10.1016/j.metabol.2005.05.007 53 HagosY.SteinD.UgeleB.BurckhardtG.BahnA

Tandio, S

Its time to make another push

The presence of these conditions may not immediately invalidate a persons plasma donation if they already have type 2 diabetes but it still underscores the need for pre-screening and an evaluation on a case-by-case basis

What This Signals for The Future of Weight Loss Drug Competition Hims & Hers abandons copycat weight-loss drug in face of FDA probe Financial Times (@FT) February 7, 2026 This episode signals tighter regulatory oversight of compounded GLP 1 medications going forward